WHO: Measuring Transparency in the Public Pharmaceutical Sector

  • By: World Health Organization (WHO)
  • Published Date: January 2009
  • Download File Format: PDF
  • Download File Size: 1,427.96 KB
Download File

 

The WHO has initiated the Good Governance for Medicines (GGM) programme in an attempt to curb corruption in pharmaceutical sector systems by increasing transparency and accountability and promoting ethical practices. The GGM programme offers a three-step technical support package, namely national transparency assessment, development of national GGM programme, and implementation, to obtain a picture of the level of transparency and potential vulnerability to corruption in the public pharmaceutical sector using WHO’s assessment instrument. The assessment looks at six functions: registration of medicines, control of medicines promotion, inspection of establishments, selection of essential medicines, procurement and distribution.